-
Kinghorn, Van der Merwe return for Scotland against Six Nations strugglers Wales
-
Repsol says could boost Venezuela oil output over 50% in 12 months
-
UN says Israeli actions raise 'ethnic cleansing' fears in West Bank, Gaza
-
Arteta tells faltering leaders Arsenal to harness Wolves 'pain' against Spurs
-
Crowley gets nod for Irish as Prendergast drops out
-
Unbeaten Swiss to meet Great Britain in Olympic men's curling semis
-
UK police arrest ex-prince Andrew on suspicion of misconduct
-
Oil extends gains on US-Iran tensions, Europe stocks slide
-
Former prince Andrew, a historic downfall
-
Sri Lanka post 178-7 against Zimbabwe ahead of T20 Super Eights
-
OpenAI's Altman tells leaders regulation 'urgently' needed
-
US renews threat to leave IEA
-
Liverpool boss Slot says Isak in 'final stages of rehab'
-
Airbus ready to build two new European fighter jets if 'customers' ask
-
UN Sudan probe finds 'hallmarks of genocide' in El-Fasher
-
Costelow starts, Hamer-Webb makes Wales debut in Six Nations clash with Scotland
-
Facing US warnings, Iran defends right to nuclear enrichment
-
Ex-South Korea leader Yoon gets life in prison for insurrection
-
OpenAI's Altman says at India summit regulation 'urgently' needed
-
British couple held in Iran sentenced to 10 years
-
West Indies ease past Italy to tune up for T20 Super Eights
-
At least 16 killed after building collapses in Pakistan following blast
-
Summit photo op fails to unite AI startup rivals
-
OpenAI's Altman says world 'urgently' needs AI regulation
-
Horror comics boom in our age of anxiety
-
Turkey fires up coal pollution even as it hosts COP31
-
London fashion week opens with tribute to one of its greats
-
Ex-S.Korea leader Yoon gets life in prison for insurrection
-
Pea soup, veggie mash contest warms up Dutch winter
-
South Korea's Yoon: from rising star to jailed ex-president
-
Private companies seek to import fuel amid Cuban energy crisis
-
India search for 'perfect game' as South Africa loom in Super Eights
-
India's Modi calls for inclusive tech at AI summit
-
Airbus planning record commercial aircraft deliveries in 2026
-
Elections under fire: Colombia endures deadliest campaign in decades
-
Traore backs 'hungry' Italy against France in Six Nations
-
All-rounder Curran brings stuttering England to life at the death
-
South Korea court weighs death sentence for ex-president Yoon
-
Tech chiefs address India AI summit as Gates cancels
-
Australia rejects foreign threats after claim of China interference
-
Somali militias terrorise locals after driving out Al-Qaeda
-
Peru picks Balcazar as interim president, eighth leader in a decade
-
Australian defence firm helps Ukraine zap Russian drones
-
General strike to protest Milei's labor reforms starts in Argentina
-
Cuban opposition figure Ferrer supports Maduro-like US operation for Cuba
-
High-stakes showdown in Nepal's post-uprising polls
-
Asian markets rally after Wall St tech-led gains
-
After Greenland, Arctic island Svalbard wary of great powers
-
Veteran Slipper set for new Super Rugby landmark
-
Sudan's historic acacia forest devastated as war fuels logging
Ghostwriters, polo shirts, and the fall of a landmark pesticide study
A flagship study that declared the weedkiller Roundup posed no serious health risks has been retracted with little fanfare, ending a 25-year saga that exposed how corporate interests can distort scientific research and influence government decision-making.
Published in Regulatory Toxicology and Pharmacology in 2000, the paper ranks in the top 0.1 percent of citations among studies on glyphosate -- the key ingredient in Roundup, owned by agri-giant Monsanto and at the center of cancer lawsuits worth billions of dollars.
In his retraction note last week, the journal's editor-in-chief, Martin van den Berg, cited a litany of serious flaws from failing to include carcinogenicity studies available at the time to undisclosed contributions by Monsanto employees and even questions around financial compensation.
Elsevier, the journal's Dutch publisher, told AFP in a statement that it upholds the "highest standards of rigor and ethics" and that "as soon as the current editor became aware of concerns regarding this paper a matter of months ago, due process began."
But it did not address the fact that concerns date back to 2002, when critics wrote to Elsevier about "conflicts of interest, lack of transparency, and the absence of editorial independence" at the journal, including specific worries about Monsanto.
The matter exploded into public view in 2017, when internal corporate documents released during litigation showed one of Monsanto's own scientists admitting to "ghostwriting."
Harvard University science historian Naomi Oreskes, who co-authored a paper this September detailing the extent of the "fraud" in the 2000 study, told AFP that while she was "very gratified" at the "long overdue" action, but warned that "the scientific community needs better mechanisms to identify and retract fraudulent papers."
"This is completely in alignment with what we were calling them out for at the time," Lynn Goldman, a pediatrician and epidemiologist at GWU who co-signed the 2002 letter, added to AFP.
- Polo shirts -
Two of the paper's three original authors have since died, while first author Gary Williams, a professor at New York Medical College, did not respond to AFP's request for comment.
Monsanto maintains it acted appropriately, and that its product is safe. "Monsanto's involvement with the Williams et al paper did not rise to the level of authorship and was appropriately disclosed in the acknowledgments."
The company declined to comment on internal emails that suggested otherwise, including one in which a Monsanto scientist asked a colleague whether "the team of people" who worked on the Williams paper and another study "could receive Roundup polo shorts as a token of appreciation for a job well done."
Glyphosate was brought to market as a herbicide in the 1970s and initially welcomed as less toxic than DDT.
But its soaring use -- especially after Monsanto introduced glyphosate-tolerant seeds that allowed it to be sprayed widely over crops -- drew increasing scrutiny in the 1990s, making the 2000 paper hugely influential.
According to Oreskes's research, it was cited as supporting evidence for glyphosate's safety by groups ranging from the Canadian Forest Service to the International Court of Justice, the US Congress and the European Parliamentary Research Service.
- Legal interest -
In 2015, the World Health Organization's International Agency for Research on Cancer classified glyphosate as "probably carcinogenic to humans."
Several countries have since moved to restrict or ban its use, including France, which has prohibited household applications. Bayer, which acquired Monsanto, said it would phase out Roundup for US residential use in 2023 in response to growing lawsuits.
Nathan Donley, a scientist with the Center for Biological Diversity, told AFP he does not expect the retraction to sway the US Environmental Protection Agency, now under the pro-agricultural-industry Donald Trump administration, which has thrown its weight behind Bayer in an ongoing Supreme Court case.
But "it could play a role in litigation that is moving forward in the US against the EPA's proposed decision to renew glyphosate," Donley told AFP, adding that European regulators might also take note.
For Donley and others, the deeper concern is that the case may be far from unique.
"I am sure there (are a) lot (of) such ghost-written and undeclared conflict papers in the literature, but they are very difficult to unearth unless one goes really deep in litigation cases," John Ioannidis, a Stanford University professor who founded the field of meta-research told AFP.
P.Stevenson--AMWN